Emvision Medical Devices Ltd Capital Reinvestment Ratio

Latest as of December 2022: 0.01x

Emvision Medical Devices Ltd capital reinvestment ratio. Emvision Medical Devices Ltd (EMV) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow (AU$2.92 Million) in capital expenditures (AU$20.23K). Check EMV cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

AU$2.92 Million
AUD

Capital Expenditures

AU$20.23K
AUD

Data as of

Dec 2022
Most recent filing

Capital Reinvestment Ratio of Emvision Medical Devices Ltd (2023–2023)

Capital reinvestment ratio of Emvision Medical Devices Ltd from 2023 to 2023. This chart tracks Emvision Medical Devices Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Emvision Medical Devices Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Emvision Medical Devices Ltd Capital Reinvestment Ratio by Year (2023–2023)

Emvision Medical Devices Ltd capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see EMV cash flow conversion.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2023 0.22x AU$834.15K AU$187.29K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow